Dark

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ

Market Open

May 5, 2026 3:47:09 PM EDT

7.98USD+1.527%(+0.12)1,080

6.70Bid 9.54Ask 2.84Spread

Pre-market

0.00USD-100.000%(-7.86)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

7.28M

Industry

Biotechnology

Next Earnings

May 13, 2026 (7d)

Last Split

May 15, 20251for28reverse

RNAZ Stats

Avg. Vol. 10 Day

5,111

Avg. Vol. 30 Day

5,928

Employees

Market Cap

7,280,726

Shares Out.

916,968

On/Off Exchange

45%/55%

6 Month Beta

0.38

1 Year Beta

0.22

2 Year Beta

0.15

3 Year Beta

-0.11

52 Week Low

6.08

52 Week High

20.99

SMA50

9.00

SMA200

9.91

1 Week

-5.48%

1 Month

-11.38%

3 Month

-10.89%

6 Month

-14.53%

1 Year

-21.69%

2 Year

-98.95%

5 Year

-100.00%

Profile

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.

RNAZ Stock Summary

TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $7.98, and today's volume is 1,080. RNAZ is up 1.527% today. The 30 day average volume is 5,928. RNAZ market cap is 7.28M with 916,968 shares outstanding.

.dark-mode .cFcqSm{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .cFcqSm{ color: #333333; background-color: white; border: 2px solid #333333; }RNAZTransCode Therapeutics, Inc. Common Stockstock NASDAQ

RNAZ Stock Summary

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ